Tramadol
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Crispin, Ralivia ER, Ralivia Flashtab, Tramadol HCl BP/EP, Tramal, Ultram, Zydol, Tridural, Tramadol HCl, Tramadol hydrochloride, Tramadolum, Tramodol Hcl, tramadol
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Dosing and Administration
For the short-term (five days or less) management of acute pain, the recommended dose of ULTRACET
is 2 tablets every 4 to 6 hours as needed for pain relief up to a maximum of 8 tablets per day.
Individualization of Dose
Low Creatinine Clearance
In patients with creatinine clearances of less than 30 mL/min, it is recommended that the dosing interval
of ULTRACET be increased not to exceed 2 tablets every 12 hours.
Elderly
Dose selection for an elderly
patient should be cautious, in view of the potential for greater sensitivity to adverse events.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Tramadol
Return to top
Publication Resources
Most Recent Articles on Tramadol
Review Articles on Tramadol
Articles on Tramadol in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Tramadol
Return to top
Trial Resources
Ongoing Trials with Tramadol at Clinical Trials.gov
Trial Results with Tramadol
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Tramadol
Cochrane Collaboration on Tramadol
Cost Effectiveness of Tramadol
Return to top
Media Resources
Powerpoint Slides on Tramadol
Images of Tramadol
Podcasts & MP3s on Tramadol
Videos on Tramadol
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Tramadol
Discussion Groups on Tramadol
Patient Handouts on Tramadol
Blogs on Tramadol
Tramadol in the News
Tramadol in the Marketplace
Return to top
International Resources
Tramadol en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
